Maxitrol Shortage Update: What Patients Need to Know in 2026

If you've been prescribed Maxitrol eye drops or ointment and your pharmacy is telling you it's out of stock, you're understandably concerned. Here's the latest information on Maxitrol availability in 2026 and what you can do to make sure your eye condition gets treated promptly.

Is Maxitrol Officially in Shortage in 2026?

As of 2026, Maxitrol (neomycin/polymyxin B/dexamethasone ophthalmic) is not listed on the FDA's official Drug Shortage Database as an active shortage. The FDA defines a drug shortage as a period when national demand exceeds national supply. By this measure, Maxitrol does not currently meet the threshold for a declared national shortage.

However, many patients and eye care providers have reported difficulty finding Maxitrol at specific pharmacies. This is a common experience with specialty ophthalmic medications — national availability can be adequate while local or regional stock is temporarily depleted.

What Makes Maxitrol Availability Inconsistent?

Unlike high-demand drugs like ADHD medications or GLP-1 weight-loss drugs, Maxitrol is not experiencing the kind of widespread demand spike that creates national shortages. The availability issues patients experience are typically caused by:

Localized distribution gaps: Pharmaceutical distributors may be slow to restock specific pharmacy locations, especially smaller ones.

Seasonal demand: Eye infection rates tend to be higher during allergy seasons and summer months, temporarily outpacing local pharmacy stock.

Generic market dynamics: With multiple generic manufacturers producing neomycin/polymyxin B/dexamethasone, pricing and supply can fluctuate as different manufacturers adjust production.

Small pharmacy stock levels: Independent and rural pharmacies often carry smaller quantities of specialty ophthalmic drugs, making them more vulnerable to temporary stockouts.

A Brief History of Maxitrol Availability

Maxitrol was first approved by the FDA in October 1964 and has been on the market for over 60 years, distributed by Alcon Laboratories. The medication has a long, stable history without the kind of formal shortage declarations that affect drugs like amoxicillin or ADHD medications. Generic versions have been available for many years, which means multiple manufacturers produce the active ingredients, providing some supply redundancy.

This stability is reassuring, but it doesn't mean patients will never encounter an empty shelf. Ophthalmic medications as a category tend to be stocked in smaller quantities than high-volume drugs, making temporary local stockouts more likely.

What Should Patients Do If Maxitrol Is Out of Stock?

If your pharmacy doesn't have Maxitrol in stock, don't wait — bacterial eye infections can worsen quickly. Here's what to do:

Use medfinder: medfinder.com calls pharmacies near you to check which ones have Maxitrol in stock, so you don't have to make dozens of calls yourself.

Request the generic: Ask your pharmacist whether the generic neomycin/polymyxin B/dexamethasone ophthalmic is available if the brand-name Maxitrol is not.

Call multiple pharmacies: Chain pharmacies like CVS, Walgreens, Walmart, and Costco often have stock when smaller pharmacies don't.

Ask about alternatives: Talk to your prescriber about switching to TobraDex (tobramycin/dexamethasone) or another appropriate substitute. See our guide on Maxitrol alternatives for a full comparison.

How to Stay Informed About Maxitrol Availability

The best resource for tracking official FDA shortage status is the FDA Drug Shortage Database at fda.gov. For local pharmacy availability, calling ahead or using a service like medfinder is more practical than checking national databases, which reflect supply at a national level rather than individual pharmacy stock.

The Outlook for Maxitrol in 2026

With no active FDA shortage declaration and multiple generic manufacturers producing neomycin/polymyxin B/dexamethasone, the overall supply outlook for Maxitrol in 2026 is stable. Patients who experience local stockouts can generally find the medication — brand or generic — at a different nearby pharmacy with some persistence. If availability is a recurring problem for you, talk to your prescriber about whether a suitable alternative with potentially better local availability makes sense for your care.